Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitor

Réjean Ruel, Carl Thibeault, Alexandre L’Heureux, Alain Martel, Zhen‐Wei Cai, Donna Wei, Ligang Qian, Joel C. Barrish, Arvind Mathur, Celia D’Arienzo,

Bioorganic & Medicinal Chemistry Letters · 2008 · 19 citations · 12 references

DOIFull text

Open access

Concepts

References

12